Srabani Mittal1, Ranajit Mandal1, Dipanwita Banerjee1, Pradip Das1, Ishita Ghosh1, Chinmay Panda1, Jaydip Biswas1, Partha Basu2,3. 1. Chittaranjan National Cancer Institute, 37, S. P. Mukherjee Road, Kolkata, 700026, India. 2. Chittaranjan National Cancer Institute, 37, S. P. Mukherjee Road, Kolkata, 700026, India. BasuP@iarc.fr. 3. Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer (WHO), 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France. BasuP@iarc.fr.
Abstract
PURPOSE: A demonstration project was conducted to assess feasibility of implementing HPV detection-based cervical cancer screening in primary care settings in India and to generate local evidence on feasibility and effectiveness of HPV detection in primary screening. METHODS: The project was implemented by setting up screening clinics at primary health centers. Eligible women were screened by HPV DNA test (Hybrid capture 2). All samples were processed and tested in a single laboratory. Colposcopy services were provided to screen-positive women at the same community clinics. Project utilized services of community health workers for community mobilization, recall of screen-positive and disease-positive women. Women with ≥CIN2 diagnosis were treated at tertiary hospital. RESULTS: Totally, 44,110 women were screened and HPV positivity was 4.7 %. Compliance to recall of HC2-positive women for colposcopy was 78 %. Detection rate of CIN3+ by HPV test was 3.9/1,000 women. Compliance of women to treatment was 80.1 %. However, compliance of HPV-positive women for follow-up at 1 year was poor (23.2 %). Concurrent use of VIA to screen the women did not have any advantage but increased number of unnecessary colposcopies and biopsies. CONCLUSIONS: Our project demonstrated that it was possible to implement HPV detection-based screening using existing primary healthcare infrastructure. Performing colposcopy at primary setting is feasible, improves compliance and reduces over-treatment. In settings with low to moderately high HPV prevalence, direct referral of HPV-positive women is advisable. Community health workers can be effectively used for recalling the positive women.
PURPOSE: A demonstration project was conducted to assess feasibility of implementing HPV detection-based cervical cancer screening in primary care settings in India and to generate local evidence on feasibility and effectiveness of HPV detection in primary screening. METHODS: The project was implemented by setting up screening clinics at primary health centers. Eligible women were screened by HPV DNA test (Hybrid capture 2). All samples were processed and tested in a single laboratory. Colposcopy services were provided to screen-positive women at the same community clinics. Project utilized services of community health workers for community mobilization, recall of screen-positive and disease-positive women. Women with ≥CIN2 diagnosis were treated at tertiary hospital. RESULTS: Totally, 44,110 women were screened and HPV positivity was 4.7 %. Compliance to recall of HC2-positive women for colposcopy was 78 %. Detection rate of CIN3+ by HPV test was 3.9/1,000 women. Compliance of women to treatment was 80.1 %. However, compliance of HPV-positive women for follow-up at 1 year was poor (23.2 %). Concurrent use of VIA to screen the women did not have any advantage but increased number of unnecessary colposcopies and biopsies. CONCLUSIONS: Our project demonstrated that it was possible to implement HPV detection-based screening using existing primary healthcare infrastructure. Performing colposcopy at primary setting is feasible, improves compliance and reduces over-treatment. In settings with low to moderately high HPV prevalence, direct referral of HPV-positive women is advisable. Community health workers can be effectively used for recalling the positive women.
Entities:
Keywords:
Cervical cancer screening; Cervical intraepithelial neoplasia; Colposcopy services; Community mobilization; Demonstration project; Human papillomavirus detection; Hybrid capture 2
Authors: Margaret Z Wang; Rui-Mei Feng; Shaoming Wang; Xian-Zhi Duan; Dong Li; Xun Zhang; Rong Mu; Youlin Qiao; Jennifer S Smith Journal: Sex Transm Dis Date: 2019-08 Impact factor: 2.830
Authors: Audrey R Murchland; Anna Gottschlich; Kristin Bevilacqua; Andres Pineda; Berner Andrée Sandoval-Ramírez; Christian S Alvarez; Gina S Ogilvie; Thomas E Carey; Mark Prince; Michael Dean; Carlos Mendoza Montano; Alvaro Rivera-Andrade; Rafael Meza Journal: BMJ Open Date: 2019-10-28 Impact factor: 3.006